Filtered By:
Source: Bulletin du Cancer
Countries: France Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 473 results found since Jan 2013.
Thromboembolic disease and cancer: Attitude and practice of general practitioners. A qualitative study
DISCUSSION: The question of etiology of cancer remains unanswered. General practioners would like to be made aware of a common, codified attitude. This raises the question of the applicability of the recommendations. The aim is to avoid misdiagnosing a cancer or delaying a diagnosis, while at the same time, not unnecessarily exposing certain patients to excessive investigations when these are not needed. So, it is time to think about better dissemination of recommendations, tools to help GPs easily finding what they need among the multitude of existing recommendations and tools, to establish better collaboration between ge...
Source: Bulletin du Cancer - September 10, 2023 Category: Cancer & Oncology Authors: Andr éa Barbarit Cyrielle Guyon Elodie Poupin Bernard Fr èche Source Type: research
Ethical principles for the design of a clinical trial in oncology
The objective of this work is to report on the main problematic issues identified during the evaluation of oncology dossiers by the REC in order to present the expected elements and thus optimise the evaluation procedures.METHODS: The National Conference of the Research Ethics Committees analysed the questions raised by the REC during their evaluation of clinical trials of oncology drugs submitted to the European information system in 2022.RESULTS: Out of a total of fourteen dossiers, nine were subject to ethical questions on the protocol and all dossiers required modifications to the information documents.DISCUSSION: The ...
Source: Bulletin du Cancer - September 9, 2023 Category: Cancer & Oncology Authors: Claire Bahans Bettina Couderc Sophie Leymarie Fran çois Hirsch Fran çois Chapuis Virginie Rage-Andrieu Source Type: research
Organizational and budgetary impacts of the implementation of CAR-T cell therapies in a French academic hospital
This study highlighted the workload generated by the management of these new therapies, as well as the fragile balance of financing hospital stays. To date, it seems necessary and even essential to adapt the quotations of the acts dedicated to CAR-T cells activity and to provide adequate funding through an adapted pricing system.PMID:37679208 | DOI:10.1016/j.bulcan.2023.06.011
Source: Bulletin du Cancer - September 7, 2023 Category: Cancer & Oncology Authors: Lucas Fleta M élanie Gauthier Pauline Lider Arnaud Campidelli B éatrice Demoré Dani èle Bensoussan Lo ïc Reppel Source Type: research
Real-world dostarlimab use in advanced/recurrent endometrial cancer in France
DISCUSSION: The enrolment of 80 patients in an 8-month period highlights the need for access to novel treatment regimens in France for these patients post-platinum. Prospective randomized studies are ongoing to assess the efficacy and safety of dostarlimab and other checkpoint inhibitors as first-line treatment in patients with endometrial cancer.PMID:37659907 | DOI:10.1016/j.bulcan.2023.06.009
Source: Bulletin du Cancer - September 2, 2023 Category: Cancer & Oncology Authors: Manuel Rodrigues Lauriane Eberst Philippe Follana Ludiane Gauthier Virginie Jacquemin Christophe Tessier Nadia El Mouaddin Philippe Boudier Frederic Fiteni Eurydice Angeli Sophie Roche Nicolas Delanoy Renaud Sabatier Ronan Flippot Thibault de la Motte Rou Source Type: research
French recommendations for malignant pheochromocytomas and paragangliomas by the national ENDOCAN-COMETE network
Bull Cancer. 2023 Aug 10:S0007-4551(23)00297-7. doi: 10.1016/j.bulcan.2023.06.002. Online ahead of print.ABSTRACTPheochromocytomas and paragangliomas are rare neuroendocrine tumors, developed respectively in the adrenal medulla and in extra-adrenal locations. Their malignancy is defined by the presence of distant metastases. Forty percent of them are inherited and can be part of different hereditary syndromes. Their management is ensured in France by the multidisciplinary expert centers of the ENDOCAN-COMETE national network "Cancers of the Adrenal gland", certified by the National Cancer Institute and discussed within mul...
Source: Bulletin du Cancer - August 12, 2023 Category: Cancer & Oncology Authors: Christelle de la Fouchardi ère Magalie Haissaguerre Myriam Decaussin-Petrucci Karine Renaudin Fr éderic Deschamps Eric Miralli é Thibaut Murez Fran çois Pattou Laurence Rocher Pierre-Henri Savoie Matthieu Faron David Taieb Antoine Tabarin J érôme Be Source Type: research
Recommandations pour la pratique clinique Nice/Saint-Paul-de-Vence 2022 –2023 : Prise en charge du cancer du col de l'utérus avancé
Bull Cancer. 2023 Jun;110(6S):6S44-6S50. doi: 10.1016/S0007-4551(23)00333-8.ABSTRACTFrench recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2022-2023: Management of advanced cervical cancer The prognosis of cervical cancer remained pejorative until recently, first-line treatment consisting of platinum-based chemotherapy, associated with bevacizumab whenever possible, without any other therapeutic innovation for several years. However in 2022, immunotherapy appeared in the therapeutic landscape. Pembrolizumab can now be prescribed, thanks to the early access status granted by the HAS in September 2022, in pat...
Source: Bulletin du Cancer - August 12, 2023 Category: Cancer & Oncology Authors: Patricia Pautier Catherine Genestie Laurence Gladieff Jean-Emmanuel Kurtz Alain Lortholary Thibault de La Motte Rouge Anne-Lise Gaillard Anne Ducassou Coraline Dubot Etienne Rouleau Fabrice Narducci Sylvain Demontoy Christophe Hennequin Source Type: research
French recommendations for malignant pheochromocytomas and paragangliomas by the national ENDOCAN-COMETE network
Bull Cancer. 2023 Aug 10:S0007-4551(23)00297-7. doi: 10.1016/j.bulcan.2023.06.002. Online ahead of print.ABSTRACTPheochromocytomas and paragangliomas are rare neuroendocrine tumors, developed respectively in the adrenal medulla and in extra-adrenal locations. Their malignancy is defined by the presence of distant metastases. Forty percent of them are inherited and can be part of different hereditary syndromes. Their management is ensured in France by the multidisciplinary expert centers of the ENDOCAN-COMETE national network "Cancers of the Adrenal gland", certified by the National Cancer Institute and discussed within mul...
Source: Bulletin du Cancer - August 12, 2023 Category: Cancer & Oncology Authors: Christelle de la Fouchardi ère Magalie Haissaguerre Myriam Decaussin-Petrucci Karine Renaudin Fr éderic Deschamps Eric Miralli é Thibaut Murez Fran çois Pattou Laurence Rocher Pierre-Henri Savoie Matthieu Faron David Taieb Antoine Tabarin J érôme Be Source Type: research
Recommandations pour la pratique clinique Nice/Saint-Paul-de-Vence 2022 –2023 : Diagnostic histomoléculaire des carcinomes de l'endomètre
Bull Cancer. 2023 Jun;110(6S):6S10-6S19. doi: 10.1016/S0007-4551(23)00330-2.ABSTRACTFrench recommendations for clinical practice Nice-Saint-Paul de Vence 2022-2023: histomolecular diagnosis of endometrial carcinomas The characterisation of endometrial carcinomas has been recently modified and enriched by molecular classification, the integration of which now impacts therapeutic decisions on whether adjuvant therapy should be administered or not in localized tumors, and influences treatment selection in advanced disease. Mandatory information includes histological type according to WHO 2020 classification, histological grad...
Source: Bulletin du Cancer - August 12, 2023 Category: Cancer & Oncology Authors: Corinne Jeanne Isabelle Treilleux Marie-Aude Le Fr ère-Belda J érôme Alexandre Florence Joly Etienne Rouleau Source Type: research
French recommendations for malignant pheochromocytomas and paragangliomas by the national ENDOCAN-COMETE network
Bull Cancer. 2023 Aug 10:S0007-4551(23)00297-7. doi: 10.1016/j.bulcan.2023.06.002. Online ahead of print.ABSTRACTPheochromocytomas and paragangliomas are rare neuroendocrine tumors, developed respectively in the adrenal medulla and in extra-adrenal locations. Their malignancy is defined by the presence of distant metastases. Forty percent of them are inherited and can be part of different hereditary syndromes. Their management is ensured in France by the multidisciplinary expert centers of the ENDOCAN-COMETE national network "Cancers of the Adrenal gland", certified by the National Cancer Institute and discussed within mul...
Source: Bulletin du Cancer - August 12, 2023 Category: Cancer & Oncology Authors: Christelle de la Fouchardi ère Magalie Haissaguerre Myriam Decaussin-Petrucci Karine Renaudin Fr éderic Deschamps Eric Miralli é Thibaut Murez Fran çois Pattou Laurence Rocher Pierre-Henri Savoie Matthieu Faron David Taieb Antoine Tabarin J érôme Be Source Type: research
Recommandations pour la pratique clinique Nice/Saint-Paul-de-Vence 2022 –2023 : Prise en charge du cancer du col de l'utérus avancé
Bull Cancer. 2023 Jun;110(6S):6S44-6S50. doi: 10.1016/S0007-4551(23)00333-8.ABSTRACTFrench recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2022-2023: Management of advanced cervical cancer The prognosis of cervical cancer remained pejorative until recently, first-line treatment consisting of platinum-based chemotherapy, associated with bevacizumab whenever possible, without any other therapeutic innovation for several years. However in 2022, immunotherapy appeared in the therapeutic landscape. Pembrolizumab can now be prescribed, thanks to the early access status granted by the HAS in September 2022, in pat...
Source: Bulletin du Cancer - August 12, 2023 Category: Cancer & Oncology Authors: Patricia Pautier Catherine Genestie Laurence Gladieff Jean-Emmanuel Kurtz Alain Lortholary Thibault de La Motte Rouge Anne-Lise Gaillard Anne Ducassou Coraline Dubot Etienne Rouleau Fabrice Narducci Sylvain Demontoy Christophe Hennequin Source Type: research
Recommandations pour la pratique clinique Nice/Saint-Paul-de-Vence 2022 –2023 : Diagnostic histomoléculaire des carcinomes de l'endomètre
Bull Cancer. 2023 Jun;110(6S):6S10-6S19. doi: 10.1016/S0007-4551(23)00330-2.ABSTRACTFrench recommendations for clinical practice Nice-Saint-Paul de Vence 2022-2023: histomolecular diagnosis of endometrial carcinomas The characterisation of endometrial carcinomas has been recently modified and enriched by molecular classification, the integration of which now impacts therapeutic decisions on whether adjuvant therapy should be administered or not in localized tumors, and influences treatment selection in advanced disease. Mandatory information includes histological type according to WHO 2020 classification, histological grad...
Source: Bulletin du Cancer - August 12, 2023 Category: Cancer & Oncology Authors: Corinne Jeanne Isabelle Treilleux Marie-Aude Le Fr ère-Belda J érôme Alexandre Florence Joly Etienne Rouleau Source Type: research
